1. Home
  2. ADAP vs JVA Comparison

ADAP vs JVA Comparison

Compare ADAP & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • JVA
  • Stock Information
  • Founded
  • ADAP 2008
  • JVA 1971
  • Country
  • ADAP United Kingdom
  • JVA United States
  • Employees
  • ADAP N/A
  • JVA N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • JVA Packaged Foods
  • Sector
  • ADAP Health Care
  • JVA Consumer Staples
  • Exchange
  • ADAP Nasdaq
  • JVA Nasdaq
  • Market Cap
  • ADAP 21.3M
  • JVA 23.8M
  • IPO Year
  • ADAP 2015
  • JVA 2005
  • Fundamental
  • Price
  • ADAP $0.06
  • JVA $4.19
  • Analyst Decision
  • ADAP Hold
  • JVA
  • Analyst Count
  • ADAP 6
  • JVA 0
  • Target Price
  • ADAP $1.02
  • JVA N/A
  • AVG Volume (30 Days)
  • ADAP 89.0M
  • JVA 51.4K
  • Earning Date
  • ADAP 08-13-2025
  • JVA 09-12-2025
  • Dividend Yield
  • ADAP N/A
  • JVA N/A
  • EPS Growth
  • ADAP N/A
  • JVA 856.08
  • EPS
  • ADAP N/A
  • JVA 0.65
  • Revenue
  • ADAP $65,084,999.00
  • JVA $84,651,329.00
  • Revenue This Year
  • ADAP N/A
  • JVA N/A
  • Revenue Next Year
  • ADAP $52.35
  • JVA N/A
  • P/E Ratio
  • ADAP N/A
  • JVA $6.44
  • Revenue Growth
  • ADAP N/A
  • JVA 15.86
  • 52 Week Low
  • ADAP $0.05
  • JVA $1.86
  • 52 Week High
  • ADAP $1.33
  • JVA $9.93
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 29.42
  • JVA 47.20
  • Support Level
  • ADAP $0.05
  • JVA $4.05
  • Resistance Level
  • ADAP $0.09
  • JVA $4.40
  • Average True Range (ATR)
  • ADAP 0.01
  • JVA 0.15
  • MACD
  • ADAP 0.00
  • JVA -0.01
  • Stochastic Oscillator
  • ADAP 7.21
  • JVA 44.74

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

Share on Social Networks: